fda compounding semaglutide news november 2025 The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' Drugmakers battle pharmacies over compounded
Description
As demand for GLP-1 weight loss injections grows, primary care teams may need stronger counselling, safety-netting and review processes
Wang, X
The consolidation of these lawsuits into an MDL highlights the increasing legal attention and concern over the alleged serious side effects of drugs like Ozempic and Mounjaro
Mindy Kaling addressed fans who felt betrayed by her weight loss
Reproductive planning decisions must always involve your obstetrician
Its long-term data is what helps doctors and patients make informed decisions
